Robert Doebele

Insider Reports History

Entity
Individual
Location
8000 Jarvis Avenue, Suite 204, Newark, CA
Signature
/s/ Ryan Murr, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Doebele:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rain Oncology Inc. President, Chief Scientific Officer Common Stock, par value $0.001 per share 0 $0 $1.21 Jan 26, 2024 Direct
Rain Oncology Inc. President, Chief Scientific Officer Stock Option (Right to Buy) 0 Jan 26, 2024 Direct

Insider Reports Filed by Robert Doebele

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RAIN Rain Oncology Inc. Jan 26, 2024 13 $0 4 Jan 26, 2024 President, Chief Scientific Officer
RAIN Rain Oncology Inc. Aug 9, 2023 2 $0 4 Aug 11, 2023 President, Chief Scientific Officer
RAIN Rain Oncology Inc. Feb 15, 2023 1 $0 4 Feb 17, 2023 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Jul 6, 2022 2 $15.4K 4 Jul 7, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Apr 13, 2022 2 $11.9K 4 Apr 15, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Mar 31, 2022 2 $7.9K 4 Apr 4, 2022 President, Chief Scientific Officer
RAIN Rain Therapeutics Inc. Jan 7, 2022 1 $0 4 Feb 4, 2022 EVP, Chief Scientific Officer